Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Karyopharm Therapeutics | KPTI | Nov 26, 2024 | 0.88 | +4.26 |
Katapult | KPLT | Nov 26, 2024 | 6.63 | -5.01 |
Kayne Anderson BDC | KBDC | Nov 26, 2024 | 16.55 | -0.18 |
Kayne Anderson Energy Infrastructure Fund | KYN | Nov 26, 2024 | 13.28 | -0.45 |
Kazia Therapeutics ADR | KZIA | Nov 26, 2024 | 5.58 | +1.60 |
KB Financial Group ADR | KB | Nov 26, 2024 | 69.18 | -0.83 |
KB Home | KBH | Nov 26, 2024 | 82.68 | -2.76 |
KBR | KBR | Nov 26, 2024 | 61.59 | +0.26 |
KBW Bank Powershares | KBWB | Nov 26, 2024 | 71.10 | -0.32 |
KBW High Div Yield Financial Powershares | KBWD | Nov 26, 2024 | 15.42 | -0.32 |
KBW Prem Yield Equity REIT Powershares | KBWY | Nov 26, 2024 | 20.03 | +0.20 |
KBW Prop & Casuality Insur Powershares | KBWP | Nov 26, 2024 | 125.66 | +0.66 |
KBW Regional Banking Powershares | KBWR | Nov 26, 2024 | 67.58 | -1.04 |
KE Holdings | BEKE | Nov 26, 2024 | 18.72 | +1.74 |
Kearny Financial | KRNY | Nov 26, 2024 | 8.07 | -1.71 |
Keen Vision Acquisition | KVAC | Nov 26, 2024 | 10.87 | 0.00 |
Keen Vision Acquisition | KVACU | Nov 26, 2024 | 10.90 | -0.82 |
Kellanova | K | Nov 26, 2024 | 81.13 | +0.02 |
Kelly Services A | KELYA | Nov 26, 2024 | 14.67 | -1.21 |
Kelly Services B | KELYB | Nov 26, 2024 | 14.59 | -5.83 |
Kemper | KMPR | Nov 26, 2024 | 71.57 | -0.53 |
Kennametal | KMT | Nov 26, 2024 | 28.51 | -3.03 |
Kennedy-Wilson | KW | Nov 26, 2024 | 11.48 | +2.41 |
Kenon Holdings | KEN | Nov 26, 2024 | 29.50 | -1.21 |
Kentucky First Federal Bancorp | KFFB | Nov 26, 2024 | 2.61 | +0.38 |
Kenvue | KVUE | Nov 26, 2024 | 24.12 | -0.50 |
Keros Therapeutics | KROS | Nov 26, 2024 | 57.39 | +1.43 |
Keurig Dr Pepper | KDP | Nov 26, 2024 | 32.65 | -0.61 |
Kewaunee Scientific | KEQU | Nov 26, 2024 | 42.11 | -1.01 |
Key Tronic | KTCC | Nov 26, 2024 | 5.61 | +4.08 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.